Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal Carcinomatosis

NCT03732768 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Peritoneal Carcinomatosis
Ovarian Cancer

Interventions

DRUG: Radspherin

Sponsor

Oncoinvent Solutions AS